Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cyclopia intermedia
A South African fynbos shrub related to rooibos; mangiferin and hesperidin provide anti-diabetic, anti-cancer, and estrogenic activity; traditionally used for respiratory and menopausal symptoms.
Honeybush tea (Cyclopia intermedia) is a South African fynbos shrub traditionally used for menopausal symptoms and respiratory health. It contains bioactive compounds such as mangiferin, hesperidin, and luteolin, which contribute to its antioxidant, anti-inflammatory, and phytoestrogenic properties. Modern research suggests potential benefits for blood sugar regulation and cancer prevention, though clinical evidence remains limited.
The phytoestrogenic activity is attributed to isoflavones and coumestans that bind to estrogen receptors (ERβ > ERα), providing relief from menopausal symptoms. Mangiferin and hesperidin exhibit antioxidant effects via Nrf2 pathway activation and inhibition of NF-κB, reducing oxidative stress and inflammation. Additionally, these compounds may inhibit α-glucosidase and aldose reductase, contributing to antidiabetic effects. The anticancer potential involves induction of apoptosis and cell cycle arrest through modulation of p53 and caspase pathways.
A South African fynbos shrub related to rooibos; mangiferin and hesperidin provide anti-diabetic, anti-cancer, and estrogenic activity; traditionally used for respiratory and menopausal symptoms.
Honeybush tea (Cyclopia intermedia) is a South African fynbos shrub traditionally used for menopausal symptoms and respiratory health. It contains bioactive compounds such as mangiferin, hesperidin, and luteolin, which contribute to its antioxidant, anti-inflammatory, and phytoestrogenic properties. Modern research suggests potential benefits for blood sugar regulation and cancer prevention, though clinical evidence remains limited.
The phytoestrogenic activity is attributed to isoflavones and coumestans that bind to estrogen receptors (ERβ > ERα), providing relief from menopausal symptoms. Mangiferin and hesperidin exhibit antioxidant effects via Nrf2 pathway activation and inhibition of NF-κB, reducing oxidative stress and inflammation. Additionally, these compounds may inhibit α-glucosidase and aldose reductase, contributing to antidiabetic effects. The anticancer potential involves induction of apoptosis and cell cycle arrest through modulation of p53 and caspase pathways.